Journals / Turkish Journal of Medical Sciences / 2006 / Cilt: 36 - Sayı: 6

Trichonamas vaginalis Infection among Palestinian Women: Prevalence and Trends during 2000-2006

Pages
371–375
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results may be useful for health authorities, especially for antenatal care and protection against STDs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Trichomonas vaginalis has not been studied in Gaza and there is no available data on the prevalence of this sexually transmitted disease (STD).
📊
Key Findings & Data:The objectives of this study were to determine the prevalence of Trichomonas vaginalis (T. vaginalis) among Palestinian women attending a child and mother care center in Gaza, Palestine and to estimate the trend of prevalence over the period from 2000-2006.
💡
Conclusion & Impact:These results may be useful for health authorities, especially for antenatal care and protection against STDs.
🔬Design:Research Article
📍Scope:2000-2006 Verileri
⚙️Variables:Trichomonas vaginalis · prevalence · trends

Abstract

Aim: Trichomonas vaginalis has not been studied in Gaza and there is no available data on the prevalence of this sexually transmitted disease (STD). The objectives of this study were to determine the prevalence of Trichomonas vaginalis (T. vaginalis) among Palestinian women attending a child and mother care center in Gaza, Palestine and to estimate the trend of prevalence over the period from 2000-2006. Materials and Methods: A cross-sectional descriptive study was conducted among 430 pregnant women attending a child and mother care center in Gaza. The clinical and gynecologic examinations were performed according to the complaints reported by each woman, especially infertility. Vaginal and cervical swabs were collected and stained with Papanicolaou (Pap) stain. Results: Out of 423 women, a total of 77 were found to be infected with T. vaginalis, for a prevalence of 18.2%. A decrease in the prevalence of T. vaginalis was observed with increasing age. A significant association between vaginal discharge and T. vaginalis infection was found (P = 0.001). No clear trend was noted in the prevalence of T. vaginalis over the period from 2000-2006. Conclusions: A considerable prevalence of T. vaginalis was found among pregnant women in Gaza. These results may be useful for health authorities, especially for antenatal care and protection against STDs.

Özet

Aim: Trichomonas vaginalis has not been studied in Gaza and there is no available data on the prevalence of this sexually transmitted disease (STD). The objectives of this study were to determine the prevalence of Trichomonas vaginalis (T. vaginalis) among Palestinian women attending a child and mother care center in Gaza, Palestine and to estimate the trend of prevalence over the period from 2000-2006. Materials and Methods: A cross-sectional descriptive study was conducted among 430 pregnant women attending a child and mother care center in Gaza. The clinical and gynecologic examinations were performed according to the complaints reported by each woman, especially infertility. Vaginal and cervical swabs were collected and stained with Papanicolaou (Pap) stain. Results: Out of 423 women, a total of 77 were found to be infected with T. vaginalis, for a prevalence of 18.2%. A decrease in the prevalence of T. vaginalis was observed with increasing age. A significant association between vaginal discharge and T. vaginalis infection was found (P = 0.001). No clear trend was noted in the prevalence of T. vaginalis over the period from 2000-2006. Conclusions: A considerable prevalence of T. vaginalis was found among pregnant women in Gaza. These results may be useful for health authorities, especially for antenatal care and protection against STDs.

🔖

Cite This Article

AL-HINDI, A. İ., LUBBAD, A. M. H. (2022). Trichonamas vaginalis Infection among Palestinian Women: Prevalence and Trends during 2000-2006. Turkish Journal of Medical Sciences, Cilt: 36 - Sayı: 6, 371–375. https://ajindex.com/articles/611945

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Minkoff H, Grunebaum AN, Schwarz RJ, Feldman J, Cummings M, Crombleholme W et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Amn J Obstet Gynecol 1984; 150: 965-972.
  2. Draper D, Jones W, Heine RP, Beutz M, French JI, McGregor JA. Trichomonas vaginalis weakens human amniochorion in an in vitro model of premature membrane rupture. Infect Dis Obstet Gynecol 1995; 2: 267-274.
  3. Pastorek JG, Cotch MF, Martin DH, Eschenbach DA. The Vaginal Infections and Prematurity Study Group. Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. Clin Infect Dis 1996; 23: 1075-1080.
  4. Cotch MF, Pastorek JG, Nugent BP, Hillier SL, Gibbs RS, Martin DH et al. The Vaginal Infections and Prematurity Study Group. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1977; 24: 1-8.
  5. Rothenberg RM, Simon R, Chipperfield E. Efficacy of selected diagnostic tests for sexually transmitted disease. JAMA 1976; 236: 49-51. Krieger JN. Urologic aspects of trichomoniasis. Invest Urol 1981; 18: 411-417.
  6. Jordon JA, Lowery D, Trucco M. TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens. J Clinic Microbiol 2001; 39: 3819-3822.
  7. Crucitti T, Van Dyck E, Tehe A, Abdellati S, Vuylsteke B, Buve A et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 2003; 79(5): 393-398.
  8. Chen XS, Yin YP, Chen LP, Thuy NTT, Zhang GY, Shi MQ et al. Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, China. Sex Transm Dis 2006; 33(5): 296-301.
  9. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32(7): 446-453.
  10. Ministry of Health, Annual Report, 2004 (Palestinian Ministry of Health). Swygard H, Sena AC, Hobbs MM, Cohen MS. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Trans Infect 2004; 80: 91-95.
  11. Thomason JL, Gelbart SM. Trichomonas vaginalis. Obstet Gynecol 1989; 74: 536-541.
  12. Philip A, Carter-Scott P, Rogers C. An agar culture technique to quantitate Trichomonas vaginalis from women. J Infect Dis 1987; 155: 304-308.
  13. McLellan R, Spence MR, Brockman M, Raffel L